awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47100877-4C3E0043-F0C6-481B-B3CA-FB6503EB1E29
Q47100877-4C3E0043-F0C6-481B-B3CA-FB6503EB1E29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47100877-4C3E0043-F0C6-481B-B3CA-FB6503EB1E29
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
P2860
Q47100877-4C3E0043-F0C6-481B-B3CA-FB6503EB1E29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47100877-4C3E0043-F0C6-481B-B3CA-FB6503EB1E29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f88d8a881c7292289e615aa689287ce71da5bec5
P2860
Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.